Skip to main content
Funded Studies

Jonathan Michael Blackburn, PhD

Chief Scientific Officer at Sengenics Corporation Pte Ltd

Location: Singapore

Prof. Jonathan Blackburn is the inventor of the Sengenics KREX technology which he developed at Cambridge University. He is currently the Chief Scientific Officer of Sengenics, leading the company's R&D teams in three different locations. He graduated from the University of Oxford with a 1st Class degree in Chemistry. He obtained his Doctor of Philosophy degree in Chemistry from the University of Oxford under the supervision of Prof. Sir Jack Baldwin, FRS, and carried out post-doctoral research at the Medical Research Council (UK) with Prof. Sir Alan Fersht, FRS. In 1995, Prof. Blackburn was awarded a prestigious 10-year Royal Society University Research Fellowship (URF). Prof. Blackburn serves on a number of national and international committees, including the National Health Research Committee, the biotechnology subcommittee of the International Union of Pure and Applied Chemistry and the Industrial Advisory Board of the Human Proteome Organisation (HUPO). He also sits on the editorial advisory boards of the Journal of Proteome Research, Journal of Proteome Science and Computational Biology, and Expert Review of Proteomics.

Associated Grants

  • Identification of Autoantibodies in People at Risk of Developing Parkinson’s Disease Using Microarrays


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.